Clinical Trials Arena September 10, 2025
Innovation meets uncertainty for clinical trial supply, drawing focus to risk management as the safeguard for trial success.
Regulatory overhaul, international trade tariffs, and the burgeoning disruption imposed by artificial intelligence (AI) are moving the clinical trials industry to place greater focus on managing risk in pharmaceutical supply chains.
Risk management dominated the conversation among panellists at the opening session of the 2025 Clinical Trial Supply West Coast 2025 (CTSWC25) conference on 9 September in Burlingame, California. The panel discussed the challenges and solutions offered by shifting geopolitical and technological trends to clinical trial supply, moderated by Paul Hingst, supply chain consultant at Crinetics Pharmaceuticals.
“It seems that the unforeseen circumstances are getting bigger and more frequent: pandemic, some geopolitical...
Today's Sponsors
Today's Sponsor